Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma

Ken Kikuchi, Simone Hettmer, M. Imran Aslam, Joel E. Michalek, Wolfram Laub, Breelyn A. Wilky, David M. Loeb, Brian P. Rubin, Amy J. Wagers, Charles Keller

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Rhabdomyosarcoma is the most commonly occurring soft-tissue sarcoma in childhood. Most rhabdomyosarcoma falls into one of two biologically distinct subgroups represented by alveolar or embryonal histology. The alveolar subtype harbors a translocation-mediated PAX3:FOXO1A fusion gene and has an extremely poor prognosis. However, tumor cells have heterogeneous expression for the fusion gene. Using a conditional genetic mouse model as well as human tumor cell lines, we show that that Pax3:Foxo1a expression is enriched in G2 and triggers a transcriptional program conducive to checkpoint adaptation under stress conditions such as irradiation in vitro and in vivo. Pax3:Foxo1a also tolerizes tumor cells to clinically-established chemotherapy agents and emerging molecularly-targeted agents. Thus, the surprisingly dynamic regulation of the Pax3:Foxo1a locus is a paradigm that has important implications for the way in which oncogenes are modeled in cancer cells.

Original languageEnglish (US)
Article numbere1004107
JournalPLoS Genetics
Volume10
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Oncogene Fusion
Rhabdomyosarcoma
oncogenes
tumor
translocation
cell cycle
Cell Cycle
Gene Fusion
gene fusion
chemotherapy
Neoplasms
gene
Genetic Models
histology
Tumor Cell Line
Oncogenes
Sarcoma
cancer
Histology
irradiation

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Ecology, Evolution, Behavior and Systematics
  • Cancer Research
  • Genetics(clinical)

Cite this

Kikuchi, K., Hettmer, S., Aslam, M. I., Michalek, J. E., Laub, W., Wilky, B. A., ... Keller, C. (2014). Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma. PLoS Genetics, 10(1), [e1004107]. https://doi.org/10.1371/journal.pgen.1004107

Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma. / Kikuchi, Ken; Hettmer, Simone; Aslam, M. Imran; Michalek, Joel E.; Laub, Wolfram; Wilky, Breelyn A.; Loeb, David M.; Rubin, Brian P.; Wagers, Amy J.; Keller, Charles.

In: PLoS Genetics, Vol. 10, No. 1, e1004107, 01.2014.

Research output: Contribution to journalArticle

Kikuchi, K, Hettmer, S, Aslam, MI, Michalek, JE, Laub, W, Wilky, BA, Loeb, DM, Rubin, BP, Wagers, AJ & Keller, C 2014, 'Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma', PLoS Genetics, vol. 10, no. 1, e1004107. https://doi.org/10.1371/journal.pgen.1004107
Kikuchi, Ken ; Hettmer, Simone ; Aslam, M. Imran ; Michalek, Joel E. ; Laub, Wolfram ; Wilky, Breelyn A. ; Loeb, David M. ; Rubin, Brian P. ; Wagers, Amy J. ; Keller, Charles. / Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma. In: PLoS Genetics. 2014 ; Vol. 10, No. 1.
@article{30f92bf4b12040489d2ade253cb7638b,
title = "Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma",
abstract = "Rhabdomyosarcoma is the most commonly occurring soft-tissue sarcoma in childhood. Most rhabdomyosarcoma falls into one of two biologically distinct subgroups represented by alveolar or embryonal histology. The alveolar subtype harbors a translocation-mediated PAX3:FOXO1A fusion gene and has an extremely poor prognosis. However, tumor cells have heterogeneous expression for the fusion gene. Using a conditional genetic mouse model as well as human tumor cell lines, we show that that Pax3:Foxo1a expression is enriched in G2 and triggers a transcriptional program conducive to checkpoint adaptation under stress conditions such as irradiation in vitro and in vivo. Pax3:Foxo1a also tolerizes tumor cells to clinically-established chemotherapy agents and emerging molecularly-targeted agents. Thus, the surprisingly dynamic regulation of the Pax3:Foxo1a locus is a paradigm that has important implications for the way in which oncogenes are modeled in cancer cells.",
author = "Ken Kikuchi and Simone Hettmer and Aslam, {M. Imran} and Michalek, {Joel E.} and Wolfram Laub and Wilky, {Breelyn A.} and Loeb, {David M.} and Rubin, {Brian P.} and Wagers, {Amy J.} and Charles Keller",
year = "2014",
month = "1",
doi = "10.1371/journal.pgen.1004107",
language = "English (US)",
volume = "10",
journal = "PLoS Genetics",
issn = "1553-7390",
publisher = "Public Library of Science",
number = "1",

}

TY - JOUR

T1 - Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma

AU - Kikuchi, Ken

AU - Hettmer, Simone

AU - Aslam, M. Imran

AU - Michalek, Joel E.

AU - Laub, Wolfram

AU - Wilky, Breelyn A.

AU - Loeb, David M.

AU - Rubin, Brian P.

AU - Wagers, Amy J.

AU - Keller, Charles

PY - 2014/1

Y1 - 2014/1

N2 - Rhabdomyosarcoma is the most commonly occurring soft-tissue sarcoma in childhood. Most rhabdomyosarcoma falls into one of two biologically distinct subgroups represented by alveolar or embryonal histology. The alveolar subtype harbors a translocation-mediated PAX3:FOXO1A fusion gene and has an extremely poor prognosis. However, tumor cells have heterogeneous expression for the fusion gene. Using a conditional genetic mouse model as well as human tumor cell lines, we show that that Pax3:Foxo1a expression is enriched in G2 and triggers a transcriptional program conducive to checkpoint adaptation under stress conditions such as irradiation in vitro and in vivo. Pax3:Foxo1a also tolerizes tumor cells to clinically-established chemotherapy agents and emerging molecularly-targeted agents. Thus, the surprisingly dynamic regulation of the Pax3:Foxo1a locus is a paradigm that has important implications for the way in which oncogenes are modeled in cancer cells.

AB - Rhabdomyosarcoma is the most commonly occurring soft-tissue sarcoma in childhood. Most rhabdomyosarcoma falls into one of two biologically distinct subgroups represented by alveolar or embryonal histology. The alveolar subtype harbors a translocation-mediated PAX3:FOXO1A fusion gene and has an extremely poor prognosis. However, tumor cells have heterogeneous expression for the fusion gene. Using a conditional genetic mouse model as well as human tumor cell lines, we show that that Pax3:Foxo1a expression is enriched in G2 and triggers a transcriptional program conducive to checkpoint adaptation under stress conditions such as irradiation in vitro and in vivo. Pax3:Foxo1a also tolerizes tumor cells to clinically-established chemotherapy agents and emerging molecularly-targeted agents. Thus, the surprisingly dynamic regulation of the Pax3:Foxo1a locus is a paradigm that has important implications for the way in which oncogenes are modeled in cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=84896690221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896690221&partnerID=8YFLogxK

U2 - 10.1371/journal.pgen.1004107

DO - 10.1371/journal.pgen.1004107

M3 - Article

C2 - 24453992

AN - SCOPUS:84896690221

VL - 10

JO - PLoS Genetics

JF - PLoS Genetics

SN - 1553-7390

IS - 1

M1 - e1004107

ER -